Figure 3
From: Prognostic factors and Doxorubicin involved in malignant progression of meningioma
Functional pathway enrichment of malignant progression-related mRNAs in meningioma (A, B, C) Biological process, cellular component, and molecular function pathway enrichment (GO); (D) Kyoto Encyclopedia of Genes and Genomes pathway enrichment; (E, F) GSEA pathway enrichment of cancer markers and immunologic markers.
